Skip to main content

Table 3 Adjusted hazard ratios of product terms between ART-123 and PMX-HP and related therapeutic variables

From: Beneficial effect modification on survival outcome of sepsis between ART-123 and polymyxin B‑immobilised haemoperfusion: a nationwide Japanese registry study

 

Adjusted hazard ratio

95% confidence interval

P value

(a) Overall

 ART-123 × PMX-HP

0.667

0.462–0.961

0.030

 ART-123

0.774

0.639–0.937

0.009

 PMX-HP

0.872

0.699–1.086

0.222

(b) Patients who required vasopressors

 ART-123 × PMX-HP

0.637

0.439–0.925

0.018

 ART-123

0.790

0.649–0.960

0.018

 PMX-HP

0.889

0.710–1.112

0.301

  1. PMX-HP polymyxin B‑immobilised haemoperfusion
  2. The adjusted hazard ratio, 95% confidence interval, and P values indicate those calculated after the product term was introduced into the Cox regression model shown in Table 2 or 4